Skip to main content
. Author manuscript; available in PMC: 2019 Nov 13.
Published in final edited form as: AIDS. 2018 Nov 13;32(17):2593–2603. doi: 10.1097/QAD.0000000000001990

Figure 2.

Figure 2.

Estimated prevalence of resistance mutations and 95% confidence bands by drug class and multiclass combinations. Among all ART-experienced patients in care, 2000–2016 (Panels A and B); among ART-experienced patients in care with HIV viremia, 2000–2016 (Panels C and D); among patients in care who initiated ART in 2007 or later, 2007–2016 (Panels E and F).